The largest U.S. drugmaker agreed to pay a hefty premium of 62% for Array, which sells the combination treatment Braftovi and Mektovi for melanoma. But those drugs appear poised to become part of a promising triple combination for advanced colorectal cancer.
from Moneycontrol http://bit.ly/2XnSnJr
-
Here's an amazing recipe of a sandwich made with eggs. Eggs, as we all know, are chock-full of nutrients and everything good. from NDT...
No comments:
Post a Comment